Genzyme Financial Statements
Genzyme Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Genzyme Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 4,605.0 | 3,813.5 | 3,187.0 |
| Gross Profit ($ mil.) | 3,456.5 | 2,886.2 | 2,451.3 |
| Operating Income ($ mil.) | 630.0 | 747.8 | (37.2) |
| Total Net Income ($ mil.) | 421.1 | 480.2 | (16.8) |
| Diluted EPS (Net Income) | 1.50 | 1.74 | (0.06) |
Genzyme Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Jun 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 1,057.5 | 1,228.5 | 1,228.5 |
| Gross Profit ($ mil.) | 698.1 | 878.0 | 878.0 |
| Operating Income ($ mil.) | 16.5 | 266.4 | 266.4 |
| Total Net Income ($ mil.) | 16.0 | 187.6 | 187.6 |
| Diluted EPS (Net Income) | 0.06 | 0.68 | 0.68 |
Genzyme Stock Quote & Chart
11/06/09 16:00:01 EST •
NASDAQ •
52.28
•
 +0.2600
•
+0.4998 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Genzyme Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.13 | 7.49 | 7.00 |
| Price/Earnings Ratio | 29.76 | 92.59 | 25.45 |
| Price/Book Ratio | 1.81 | 3.46 | 6.74 |
| Price/Cash Flow Ratio | 11.27 | 41.15 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Genzyme Financial Ratios
Genzyme Competitive Intelligence
| Amicus Therapeutics | Roche Holding | Shire | |
|---|---|---|---|
| Annual Sales ($ mil.) | 15.0 | 45,355.5 | 3,022.2 |
| Employees | 115 | -- | 3,769 |
| Market Cap ($ mil.) | 97.4 | 234,796.4 | 10,027.3 |
Competitive Landscape
